
Nexera series LC-40
Shimadzu’s Nexera Ultra High-Performance Liquid Chromatograph series incorporates artificial intelligence as analytical intelligence and allows systems to detect and resolve issues automatically. Read more.
Nexera series LC-40 - Groundbreaking technology
Shimadzu’s Nexera Ultra High-Performance Liquid Chromatograph series, incorporates artificial intelligence as Analytical Intelligence, allows systems to detect and resolve issues automatically. The
The
With remote mobile phase monitoring and integrated consumables management, the system maximizes uptime and reliability. Real-time monitoring of mobile phase levels allows lab personnel to efficiently run batches and respond accordingly if there isn’t enough mobile phase before starting a run. In addition, Nexera tracks consumable usage and sends alerts when parts need replacing, allowing users to keep the system running at peak performance. The Nexera UHPLC series allows analysts to confirm parameters and monitor chromatograms in real time directly from a web browser on their smart device.
The Nexera UHPLC increases efficiency by automating workflows and maximizing throughput analysis. The SIL-40 autosampler can process the entire injection cycle time in as little as seven seconds, and continuous analysis can be carried out on up to 44 MTPs (using 3 plate changers). The SIL-40’s plate changers enable non-stop temperature-controlled analysis of thousands of samples. The Nexera automatically blends mobile phases at any set ratio, which speeds up the preparation of buffer solutions and the dilution of solvents. Because it prepares the exact amounts required for analysis, the Nexera reduces waste and labor.
The Nexera’s elegant, compact design saves valuable bench space. Because it uses over 80% less electricity when on standby, it significantly reduces running costs and supports an environmentally-friendly lab.
To learn more, please visit:
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.


